The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

KinCon biolabs was founded in 2022 following an FFG spin-off fellowship under the mentorship of Prof. Christoph Huber. In the ...

(MENAFN- ForPressRelease) Creative Biolabs took the spotlight at the 21st BioPharma Drug Discovery Nexus conference held on ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

And this scene is taking place at BioLabs Pegasus Park in Dallas, not San Francisco or Boston. BioLabs, a 37,000-square-foot shared lab and office space for young life sciences companies ...

Tens of thousands of creatives have signed an open letter calling for change. Generative artificial intelligence companies capable of generating creative content are also said to be disrupting the ...

Georgia Sen. Raphael Warnock and Rep. Hank Johnson have written a letter to the CEO of the company that owns the BioLab chemical plant. The lawmakers have asked the CEO to provide them more ...

(RTTNews) - Virax Biolabs Group Limited (VRAX) Wednesday said that it has entered into a distribution agreement with Europa Biosite to sell Virax's portfolio of immune profiling solutions ...

On Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with Europa Biosite to commercialize the company's ImmuneSelect Research Use portfolio in the U.K. and ...

ImmuneSelect is the Company's portfolio of research products dedicated to investigating adaptive immunity. Products within the ImmuneSelect brand are for research and investigational use only and ...